HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Allogenic Dermis Construct Helps Skin Regenerate

By HospiMedica International staff writers
Posted on 12 Aug 2014
Print article
Image: DermaPure decellularized human dermis (Photo courtesy of Tissue Regenix).
Image: DermaPure decellularized human dermis (Photo courtesy of Tissue Regenix).
A decellularized biological scaffold aids natural healing by attracting the patient’s own cells to the skin wound area.

DermaPure is a decellularized human dermis product that approximates the structure and function of native dermis tissue. It is manufactured using patented dCELL technology, which maintains the essential structure of the native extracellular matrix (ECM) and preserves a high degree of natural tissue’s biomechanical properties. The remaining decellularized tructure forms a natural scaffold into which a patient’s cells can grow once it is placed onto a wound. Since Dermapure has a distinct outer basement membrane and an inner dermal surface, correct orientation is all important.

A trial in the United Kingdom has shown that patients who had had chronic wounds for an average of 4.5 years and who were treated with a single application of DermaPure saw an 87% reduction in the size of all wounds, while 60% of patients were completely healed, with virtually no recurrences. DermaPure is a product of Tissue Regenix (TRX; York, United Kingdom; www.tissueregenix.com), and does not require refrigeration or rehydration prior to use, making it suitable for use in a variety of healthcare settings, such as hospitals, community clinics, field stations, and doctors’ offices.

“DermaPure is initially being targeted at acute care patients with diabetic foot ulcers, a condition which affects around 600,000 people in the United States, and patients with venous leg ulcers, which currently affect around 2.5 million people,” said Greg Bila, president of TRX. “We see this as a large market that is in need of medical innovation, which is exactly what DermaPure provides.”

dCELL technology uses low concentration processing reagents, including sodium dodecyl sulfate (SDS), DNase, RNase, and glycerol; proteinase inhibitors are used to preserve tissue structure. The preparation process also exposes the skin to antibiotics‐‐penicillin, streptomycin, nystatin, gentamicin, vancomycin, imipenem, and polymixin B. The tissue is then treated to reduce the residual content of reagents.

Related Links:
Tissue Regenix


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Computerized Spirometer
DatospirAira

Print article

Channels

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more